These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 9931332)
1. Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Devuyst O; Christie PT; Courtoy PJ; Beauwens R; Thakker RV Hum Mol Genet; 1999 Feb; 8(2):247-57. PubMed ID: 9931332 [TBL] [Abstract][Full Text] [Related]
2. Chloride channels and endocytosis: new insights from Dent's disease and ClC-5 knockout mice. Devuyst O; Jouret F; Auzanneau C; Courtoy PJ Nephron Physiol; 2005; 99(3):p69-73. PubMed ID: 15637424 [TBL] [Abstract][Full Text] [Related]
3. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Wang SS; Devuyst O; Courtoy PJ; Wang XT; Wang H; Wang Y; Thakker RV; Guggino S; Guggino WB Hum Mol Genet; 2000 Dec; 9(20):2937-45. PubMed ID: 11115837 [TBL] [Abstract][Full Text] [Related]
4. Chloride channels and endocytosis: new insights from Dent's disease and CLC-5 knockout mice. Devuyst O Bull Mem Acad R Med Belg; 2004; 159(Pt 2):212-7. PubMed ID: 15615095 [TBL] [Abstract][Full Text] [Related]
5. ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Günther W; Lüchow A; Cluzeaud F; Vandewalle A; Jentsch TJ Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8075-80. PubMed ID: 9653142 [TBL] [Abstract][Full Text] [Related]
6. The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease. Günther W; Piwon N; Jentsch TJ Pflugers Arch; 2003 Jan; 445(4):456-62. PubMed ID: 12548389 [TBL] [Abstract][Full Text] [Related]
7. Altered polarity and expression of H+-ATPase without ultrastructural changes in kidneys of Dent's disease patients. Moulin P; Igarashi T; Van der Smissen P; Cosyns JP; Verroust P; Thakker RV; Scheinman SJ; Courtoy PJ; Devuyst O Kidney Int; 2003 Apr; 63(4):1285-95. PubMed ID: 12631345 [TBL] [Abstract][Full Text] [Related]
8. CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: relevance to pathophysiology of Dent's disease. Reed AA; Loh NY; Terryn S; Lippiat JD; Partridge C; Galvanovskis J; Williams SE; Jouret F; Wu FT; Courtoy PJ; Nesbit MA; Rorsman P; Devuyst O; Ashcroft FM; Thakker RV Am J Physiol Renal Physiol; 2010 Feb; 298(2):F365-80. PubMed ID: 19940036 [TBL] [Abstract][Full Text] [Related]
9. Dent's disease--a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Thakker R Bull Mem Acad R Med Belg; 2004; 159(Pt 2):199-211. PubMed ID: 15615094 [TBL] [Abstract][Full Text] [Related]
10. Hypertonicity increases CLC-5 expression in mouse medullary thick ascending limb cells. Pham PC; Devuyst O; Pham PT; Matsumoto N; Shih RN; Jo OD; Yanagawa N; Sun AM Am J Physiol Renal Physiol; 2004 Oct; 287(4):F747-52. PubMed ID: 15161605 [TBL] [Abstract][Full Text] [Related]
19. A role for CBS domain 2 in trafficking of chloride channel CLC-5. Carr G; Simmons N; Sayer J Biochem Biophys Res Commun; 2003 Oct; 310(2):600-5. PubMed ID: 14521953 [TBL] [Abstract][Full Text] [Related]
20. [Dent's disease: hereditary nephrolithiasis related to defective tubular endocytosis processes]. Tosetto E; Anglani F; Graziotto R; Citron L; D'Angelo A; Gambaro G G Ital Nefrol; 2003; 20(6):578-88. PubMed ID: 14732909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]